Sino-US healthcare investment specialist Vivo Capital has scored more than $740m for the third cycle of its evergreen Opportunity Fund, which targets small and mid-cap biotech and life science companies.
The post Vivo Capital looks to capture value from medical breakthroughs with $740m boost to evergreen fund appeared first on AltAssets Private Equity News.
The venture capital arm of German engineering and tech major Bosch has launched a €250m fund targeting developing tech areas such as energy efficiency and AI.
The post Bosch venture capital arm unveils €250m cutting-edge tech investment fund appeared first on AltAssets Private Equity News.
